S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   419.58 (-0.90%)
AAPL   165.44 (-0.96%)
MSFT   400.77 (-0.87%)
META   487.66 (-2.82%)
GOOGL   154.77 (-0.79%)
AMZN   176.19 (-1.69%)
TSLA   149.89 (-0.03%)
NVDA   819.22 (-3.25%)
AMD   151.03 (-2.61%)
NIO   3.88 (-3.00%)
BABA   68.75 (-0.19%)
T   16.38 (+0.31%)
F   12.13 (+0.58%)
MU   109.50 (-2.17%)
GE   151.20 (-1.14%)
CGC   7.76 (-0.89%)
DIS   112.11 (-0.28%)
AMC   3.22 (+10.27%)
PFE   25.59 (+0.79%)
PYPL   62.18 (+0.13%)
XOM   120.71 (+1.85%)
S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   419.58 (-0.90%)
AAPL   165.44 (-0.96%)
MSFT   400.77 (-0.87%)
META   487.66 (-2.82%)
GOOGL   154.77 (-0.79%)
AMZN   176.19 (-1.69%)
TSLA   149.89 (-0.03%)
NVDA   819.22 (-3.25%)
AMD   151.03 (-2.61%)
NIO   3.88 (-3.00%)
BABA   68.75 (-0.19%)
T   16.38 (+0.31%)
F   12.13 (+0.58%)
MU   109.50 (-2.17%)
GE   151.20 (-1.14%)
CGC   7.76 (-0.89%)
DIS   112.11 (-0.28%)
AMC   3.22 (+10.27%)
PFE   25.59 (+0.79%)
PYPL   62.18 (+0.13%)
XOM   120.71 (+1.85%)
S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   419.58 (-0.90%)
AAPL   165.44 (-0.96%)
MSFT   400.77 (-0.87%)
META   487.66 (-2.82%)
GOOGL   154.77 (-0.79%)
AMZN   176.19 (-1.69%)
TSLA   149.89 (-0.03%)
NVDA   819.22 (-3.25%)
AMD   151.03 (-2.61%)
NIO   3.88 (-3.00%)
BABA   68.75 (-0.19%)
T   16.38 (+0.31%)
F   12.13 (+0.58%)
MU   109.50 (-2.17%)
GE   151.20 (-1.14%)
CGC   7.76 (-0.89%)
DIS   112.11 (-0.28%)
AMC   3.22 (+10.27%)
PFE   25.59 (+0.79%)
PYPL   62.18 (+0.13%)
XOM   120.71 (+1.85%)
S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   419.58 (-0.90%)
AAPL   165.44 (-0.96%)
MSFT   400.77 (-0.87%)
META   487.66 (-2.82%)
GOOGL   154.77 (-0.79%)
AMZN   176.19 (-1.69%)
TSLA   149.89 (-0.03%)
NVDA   819.22 (-3.25%)
AMD   151.03 (-2.61%)
NIO   3.88 (-3.00%)
BABA   68.75 (-0.19%)
T   16.38 (+0.31%)
F   12.13 (+0.58%)
MU   109.50 (-2.17%)
GE   151.20 (-1.14%)
CGC   7.76 (-0.89%)
DIS   112.11 (-0.28%)
AMC   3.22 (+10.27%)
PFE   25.59 (+0.79%)
PYPL   62.18 (+0.13%)
XOM   120.71 (+1.85%)
Free Trial
LON:CIR

Circassia Group (CIR) Share Price, News & Analysis

→ AI “wealth window” is closing soon! (From Paradigm Press) (Ad)
Free CIR Stock Alerts
GBX 34
-2.50 (-6.85%)
(As of 09/2/2022)
Compare
Today's Range
33.75
▼
34.90
50-Day Range
34
▼
34
52-Week Range
29
▼
49.95
Volume
4,513 shs
Average Volume
773,465 shs
Market Capitalization
£142.66 million
P/E Ratio
3,400.00
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
CIR stock logo

About Circassia Group Stock (LON:CIR)

Circassia Group Plc, a medical device company, focuses on the respiratory diagnostics and monitoring products in the United States, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It offers NIOX and NIOX VERO, a fractional exhaled nitric oxide measurement and monitoring products for use in asthma diagnosis and management. The company offers its products approximately in 50 countries through a network of distribution partners. The company was formerly known as Circassia Pharmaceuticals plc and changed its name to Circassia Group Plc in May 2020. Circassia Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

CIR Stock Price History

CIR Stock News Headlines

October 5, 2023 | finance.yahoo.com
Circassia Group PLC (82C.SG)
October 3, 2023 | msn.com
Discovering the Secrets of Da Vinci: Surprising Discovery About His Mother Unearthed in Historic Florence Document
April 19, 2024 | Paradigm Press (Ad)
AI “wealth window” is closing soon!
Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.
July 18, 2023 | marketwatch.com
NIOX Group 1H Revenue Rose on Clinical Revenue Increase
July 2, 2023 | insidermonkey.com
Beyond Air, Inc. (NASDAQ:XAIR) Q4 2023 Earnings Call Transcript
June 28, 2023 | benzinga.com
Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report 2023: Increasing Prevalence of Lung Disease Drives Growth
June 8, 2023 | finance.yahoo.com
Chronic Obstructive Pulmonary Disease (COPD) Treatment Global Market Report 2023
June 7, 2023 | marketwatch.com
NIOX Group Declares 2.5p Special Dividend
April 19, 2024 | Paradigm Press (Ad)
AI “wealth window” is closing soon!
Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.
May 4, 2023 | marketwatch.com
Allergy Immunotherapy Market Applications, Business Opportunities, and Strategies 2030
April 13, 2023 | marketwatch.com
Highlights 2028 Drug Allergy Treatments and Drugs Market: Regional Growth and New Advancement
April 11, 2023 | fool.co.uk
Should you buy Neil Woodford stock Circassia Pharmaceuticals after today’s price rise?
March 17, 2023 | benzinga.com
Asthma and COPD Drug Market Size Growing at 5.2% CAGR Set to Reach USD 60.3 Billion By 2032
February 11, 2023 | msn.com
Who are the Circassians of northern Israel?
September 14, 2022 | lse.co.uk
TRADING UPDATES: Epwin lifts interim payout; Anpario profit falls
September 9, 2022 | barrons.com
NIOX Group PLC
August 11, 2022 | marketwatch.com
Circassia Group to Seek Approval to Change Name to Niox Group
July 16, 2022 | marketwatch.com
Circassia Group Expects to Report Swing to 1H Adjusted Ebitda
July 14, 2022 | lse.co.uk
AIM WINNERS & LOSERS: Kibo extends contract; Appreciate CEO steps down
July 14, 2022 | lse.co.uk
Circassia ups guidance as revenue rises, overhead costs slashed
July 3, 2022 | fool.co.uk
Circassia Pharmaceuticals
July 1, 2022 | msn.com
SMALL CAP MOVERS: Deltic Energy shares rise on rig contract with Shell; Oxford BioDynamics sinks as it might need further funding
July 1, 2022 | msn.com
SMALL CAP MOVERS: Deltic Energy; Oxford BioDynamics
June 29, 2022 | marketwatch.com
Circassia to Receive $10.5 Mln After US Approval of Beyond Air's LungFit Product; Shares Rise
June 28, 2022 | seekingalpha.com
Beyond Air, Inc. (XAIR) CEO Steve Lisi on Q4 2022 Results - Earnings Call Transcript
May 12, 2022 | marketwatch.com
Circassia Shares Rise as Year-To-Date Earnings Beat Views
May 3, 2022 | nz.finance.yahoo.com
Investors in Circassia Group (LON:CIR) have unfortunately lost 65% over the last five years
See More Headlines
Receive CIR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Circassia Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/17/2020
Today
4/19/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:CIR
CUSIP
N/A
CIK
N/A
Web
www.circassia.co.uk
Phone
44 1865 405 560
Fax
N/A
Employees
111
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
3,400.00
Forward P/E Ratio
35.79
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
1.95
Current Ratio
1.83
Quick Ratio
1.50

Sales & Book Value

Annual Sales
£27.90 million
Price / Sales
5.11
Cash Flow
GBX 3 per share
Price / Cash Flow
11.33
Book Value
GBX 16 per share
Price / Book
2.13

Miscellaneous

Outstanding Shares
419,578,000
Free Float
N/A
Market Cap
£142.66 million
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover
13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Ian Roy Johnson (Age 68)
    Exec. Chairman
    Comp: $303k
  • Mr. Michael Roy David Roller A.C.A. (Age 57)
    ACA, BA (Hons), CFO & Director
    Comp: $224k
  • Mr. Jonathan Emms
    COO & Exec. Director
  • Ms. Nina Kataria
    Sr. VP Global HR
  • Ms. Sarah Duncan
    Company Sec.

Key Competitors

View All Competitors

CIR Stock Analysis - Frequently Asked Questions

How have CIR shares performed in 2024?

Circassia Group's stock was trading at GBX 34 on January 1st, 2024. Since then, CIR stock has increased by 0.0% and is now trading at GBX 34.
View the best growth stocks for 2024 here.

How were Circassia Group's earnings last quarter?

Circassia Group Plc (LON:CIR) released its earnings results on Thursday, September, 17th. The company reported ($3.00) earnings per share for the quarter.

What other stocks do shareholders of Circassia Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Circassia Group investors own include EnQuest (ENQ), boohoo group (BHOOY), Cummins (CMI), FutureFuel (FF), Trade Desk (TTD), Ascential (ASCL), H&T Group (HAT), Howden Joinery Group (HWDN), NMC Health (NMC) and Oxford Biomedica (OXB).

How do I buy shares of Circassia Group?

Shares of CIR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:CIR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research